首页 › 癌症（所有类型） › 印第安纳州 › Fort Wayne
Fort Wayne IN 癌症（所有类型）临床试验
7项针对 癌症（所有类型）的研究正在 Fort Wayne及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- Parkview Research Center /ID# 277651, Fort Wayne
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
招募中3 期
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Parkview Regional Medical Center, Fort Wayne
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
招募中3 期
- Parkview Research Center, Fort Wayne
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Fort Wayne Medical Oncology And Hematology /ID# 268179, Fort Wayne
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
招募中1 期
- GSK Investigational Site, Fort Wayne
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY109 项研究
- Boston, MA85 项研究
- Los Angeles, CA74 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Washington, DC58 项研究
- Durham, NC58 项研究
- Chicago, IL51 项研究
- Atlanta, GA49 项研究
- Seattle, WA49 项研究
- Arlington, VA48 项研究
Fort Wayne的其他研究
- 非小细胞肺癌17 项研究
- 卵巢癌8 项研究
- 慢性淋巴细胞白血病7 项研究
- 乳腺癌7 项研究
- 肺癌6 项研究
- 转移性癌症6 项研究
- 子宫内膜癌5 项研究
- 黑色素瘤4 项研究
- 头颈鳞状细胞癌4 项研究
- 三阴性乳腺癌4 项研究
- 结直肠癌4 项研究
- 多发性骨髓瘤4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。